NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE327495 Query DataSets for GSE327495
Status Public on Apr 14, 2026
Title Targeting STAT3-Mediated Lipid Metabolism Reprogramming Overcomes Chemoresistance in Acute Myeloid Leukemia
Organism Homo
Experiment type Expression profiling by high throughput sequencing
Summary Chemotherapy resistance and intolerance pose significant challenges in the effective treatment of leukemia. Among the distinctive features associated with chemoresistance, metabolic reprogramming emerges as a key factor. In this study, we unveil a novel mechanism contributing to chemoresistance in leukemia, specifically highlighting the pivotal role of altered lipid homeostasis.We found that multiple lipid metabolism processes are aberrantly activated in Ara-C resistant AML cells, with upregulation of JAK-STAT3 signaling pathways and multiple enzymes in the process of fatty acid metabolism. A potent, and highly selective STAT3 inhibitor, W1307, was designed, and exhibited significant anti-tumor activities in vitro and in vivo. Genetic and pharmacological inhibition of STAT3 leads to inhibition of lipid synthesis and catabolism, resulting lipids metabolic disorder. Mechanistically, STAT3 binds to consensus DNA response elements in the promoters of the lipid metabolism associated genes (SREBP1, CPT2) and regulates their expression. Furthermore, inhibition of STAT3 enhances the anti-tumor effect of Ara-C and sensitizes resistant AML cell line to Ara-C through disrupting lipid homeostasis and triggering lipotoxicity. Collectively, our work illuminates the pivotal role of lipid metabolism adaptation driven by STAT3 in chemoresistance. The identification of W1307 as a promising candidate compound underscores its potential as a therapeutic intervention in leukemia treatment and overcoming chemoresistance.
 
Overall design Conparative gene expression profiling analysis of RNA-seq data for MOLM-13 and MOLM-13/AR (Ara-C resistant) cells.
 
Contributor(s) Peng K, Mo J, Yang Z, Ding W
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Apr 09, 2026
Last update date Apr 14, 2026
Contact name Keren Peng
E-mail(s) pengkr3@mail2.sysu.edu.cn
Organization name Sun Yat-sen University
Street address Guangzhou University Town, Panyu District
City Guangzhou
ZIP/Postal code 510006
Country China
 
Platforms (1)
GPL35718 Illumina HiSeq 3000 (Homo)
Samples (4)
GSM9659750 MOLM-13 cells, parental, bio rep 1
GSM9659751 MOLM-13 cells, parental bio rep 2
GSM9659752 MOLM-13/AR cells, resistant, bio rep 1
Relations
BioProject PRJNA1451102

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE327495_gene_tpm_ALL_SAMPLE.txt.gz 335.1 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap